Munoz, M. “Aprepitant, When Used With Chemotherapy, Reduces the Risk of Recurrence, Metastasis, And Mortality in Patients With Breast Cancer: Aprepitant in Breast Cancer Outcomes”. Pakistan Journal of Health Sciences, vol. 7, no. 8, Aug. 2026, pp. 01-02, doi:10.54393/pjhs.v7i8.4537.